High-Dose Erythropoietin in Patients with Acute Myocardial Infarction: A Pilot, Randomised, Placebo-Controlled Study
The aim of this single-centre study was to investigate the effects of short-term high-dose erythropoietin on peripheral blood cells (PBCs) and infarct size in 30 patients with a first uncomplicated AMI undergoing percutaneous coronary intervention (PCI) who were randomly assigned to treatment with EPO (33x10(3)IU before PCI, and 24 and 48h after admission), or placebo.